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necessity	 for	 close	 clinical-academic	 collaboration	 in	 order	 to	 do	 this	 is	
highlighted.	 Finally,	 a	novel	quantitative	phase	 imaging	 technique	 is	described,	

















molecular	 signaling	 pathways,	 is	 the	 cellular	model	 that	we	 choose	 (Figure	 1).	
Ultimately,	 every	 model	 has	 its	 advantages	 and	 limitations	 but	 all	 too	 often	
perhaps	 a	model	 is	 chosen	because	 of	 cost,	 convenience	 and	 accessibility	 first,	





wasted	 funds.	 Over	 the	 years	 several	 researchers	 have	 met	 the	 challenge	 to	







search	 shows	 >8000	 references	 using	 LNCaP	 cells,	 ~4000-5000	 for	 PC3	 and	
DU145	 cells	 and	 several	 others	 (22RV1,	 RWPE-1,	 VCaP)	 coming	 in	 at	 a	 few	
hundred	references	or	fewer.	There	is	a	perception	in	the	field	that	we	need	more	
cell	 lines	 for	prostate	cancer	but	 the	concern	 is	 that	new	cell	 lines	may	not	get	






because	 the	 cell	 phenotype	 is	 retained	 and	 there	 are	 no	 oncogenic	 changes	




The	 popularity	 of	 LNCaPs	 is	 obvious	 since	 for	 decades	 the	 design	 of	 new	









The	 challenge	 with	 prostate	 cancer	 is	 to	 have	 cell	 line	 models	 that	 represent	
normal	 prostate,	 benign	 prostatic	 hyperplasia	 (BPH),	 Prostatic	 Intraepithelial	
Neoplasia	 (PIN),	 localized	 cancers	 of	 varying	 Gleason	 grades,	 aggressive	 and	
invasive	 cancers	 from	 within	 the	 prostate,	 metastatic	 cancers,	 hormone-
responsive	 cancers,	 castration-resistant	 cancers	 and	 neuroendocrine	 cancers.	
And	importantly	there	is	also	a	need	to	have	cell	lines	representing	different	races	
due	to	the	higher	incidence	of	prostate	cancer	in	African	American	men	(25).	In	
addition	 to	 the	 different	 disease	 states,	 severity	 and	 locations,	 there	 is	 further	
heterogeneity	to	take	into	account.	Prostate	cancer	is	a	multifocal	disease	so	there	
may	 be	more	 than	 one	 tumour	 in	 each	 patient	 (26)	 and	 there	 is	 inter-patient	
variability.	 Along	with	 this	 there	 is	 cellular	 heterogeneity	within	 each	 tumour,	
multiple	 gene	 mutations,	 gene	 fusions	 and	 epigenetic	 changes	 (27).	 Finding	 a	






be	 excellent	 cellular	 models	 to	 study	 the	 disease.	 They	 are	 clinically	 relevant,	
representative	of	current	disease	and	are	not	difficult	to	grow	(31-37).	However,	
one	limitation	is	that	they	can	usually	only	be	obtained	from	the	prostate	and	not	
metastatic	 sites.	 Using	 primary	 cells	 also	 opens	 up	 the	 possibility	 of	 testing	
multiple	patients	thereby	taking	into	account	patient	variation.	However,	this	also	
leads	to	the	challenge	of	assessing	and	interpreting	the	variation	in	response	that	







differential	 expression	 of	 matrix	 metalloproteinases,	 integrins,	 E-cadherin	 and	
behaviour	in	collagen	I	gels	(32,	40-42).	When	retrieving	our	samples,	we	have	a	











to	maintain	a	stem/progenitor	population	within	 the	culture	 (31,	43,	46).	 	This	
makes	comparisons	between	studies	more	challenging.	
	
Undertaking	 a	 continual	 assessment	 and	 more	 complete	 characterization	 of	
primary	epithelial	cells	in	culture	is	needed.	The	advent	of	new	techniques	means	
that	 it	 is	 both	 possible	 and	 necessary	 to	 re-visit	 the	 characterization	 of	 these	
models.	 For	 this	 reason	 we	 are	 currently	 collecting	 both	 transit	 amplifying	





Using	patient	 cells	 for	 a	 variety	of	 future	 studies	will	 ultimately	determine	 the	













the	 heterogeneous	 mixture.	 Both	 of	 these	 methods	 have	 their	 challenges;	 cell	
separation	is	a	laborious	procedure	and	it	could	be	argued	that	cells	change	their	
behaviour	when	 separate	 relative	 to	when	 they	 are	 a	mixture,	 and	 fluorescent	
labeling	by	whatever	means	always	has	the	potential	to	change	the	cell	behaviour.	
A	new	 technique	now	available	 is	 trying	 to	overcome	both	 these	challenges	by	




















of	 therapy	 resistance,	 tumour	 recurrence	 and	 identification	 of	 resistant	 cell	
features.	
	













erratic	 and	 sequentially	 rounds	 up,	 fails	 to	 divide	 and	 yet	 keeps	moving.	 Only	
further	analysis	of	outlier	cells	towards	their	ultimate	fate	will	determine	if	the	





for	 the	 progression	 of	 prostate	 cancer	 research.	 When	 addressing	 treatment	
response	and	tumour	recurrence,	there	are	several	levels	of	heterogeneity	to	take	
into	account,	which	can	only	be	done	through	use	of	patient	material.	Thus,	the	
feasibility	 of	 having	 primary	 cell	 cultures,	 which	 crucially	 represent	 modern	





been	 used	 by	 researchers	 in	 other	 cancer	 research	 fields	 and	 also	 by	 some	
researchers	 in	 the	prostate	 field	 (53-55).	 This	 is	 another	method	 that	 requires	






for	useful	 cell	 lines	but	 it	 does	highlight	 the	need	 to	 explore	 the	 cell	 lines	 that	
already	exist	because	there	may	already	be	the	correct	model	to	answer	critical	
research	 questions.	We	 also	 have	 to	 embrace	 new	 technology,	 to	 examine	 cell	
behaviour	 at	 another	 level	 of	 complexity.	 Combined	 with	 traditional	 markers	
















































































































































































































Cell Behaviour Epithelial Hierarchy




























































I I L 
C E I
I  AND 
I I L 
COLL TIONS
Collaborative network: In order to establish clinical collaborations, several parties
have to be invested and committed. There also has to be long-term continuity within
the laboratory to maintain the links and the knowledge. Once the clinical connections
are established, the tissue and cell resource attracts collaboration from other parties 
including academic departments and industry. The importance of the resource and the



























































































Response of Primary Cells to Docetaxel: (A) A time-lapse movie was generated over 72 hours with
images captured at 6 minute intervals to observe the real-time response of primary prostate cells to
docetaxel. Untreated cells could be seen moving and dividing in a continuous motion (red arrow).
Dividing cell shown in white box insert. Treated cells predominantly responded by entering mitosis
(cells rounding up – blue outline arrow) and when mitosis failed, due to the effect of docetaxel, the
cells spread out and stopped moving (blue arrow). An outlier cell was observed that continuously
rounded up to try to divide but upon failure continued moving around in an erratic fashion (yellow
arrow). (B) Kinetic and morphological features can be extracted from the data. Each cell is measured
and patterns of response recorded. Bimodal responses are observed with some parameters that can
be related to the cell behaviour (turquoise circles). (Images were captured on a LivectyeTM and data

































































































Healthy Cell Daughter 1
2
Tracking Individual Cell Behaviour: (A) Individual cells were tracked over time following 
response to docetaxel treatment (100nM). Untreated (Healthy) cell has single direction of 
movement then divides and the daughter cell has meandering directionality. Typical cell 
response to docetaxel is to round up and enter mitosis then following incomplete mitosis the 
cell stops moving. The outlier (putative resistant cell) is much more erratic in its behaviour and 
is very motile. Following attempted divisions the cell maintains its highly motile behaviour. (B) 
Individual parameters also indicate the change in cell behaviour. Thickness clearly indicates 








Patient Samples: Primary prostate epithelial cells can 
be cultured from patient tissue. These cells can be 
grown in 2D, in co-culture systems and in 3D culture. 
3D primary 
cell culture 
Co-cultures
